Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ) is now available.
Safe Supply Streaming Co Ltd. has issued a strategic corporate update as it shifts from portfolio building to active commercialization, highlighted by its first sale of a NIRLAB drug analysis device under an exclusive Canadian distribution agreement and live demonstrations of this technology to multiple levels of government and indigenous agencies in Ottawa. The company plans a corporate name and ticker change to reflect its evolution into a broader multi-vertical medical technology platform, is preparing to commercialize its proprietary rapid testing strips through government, institutional and direct-to-consumer channels in Canada and the United States, is advancing GLP-1-based health and wellness initiatives to differentiate its offerings, and has bolstered its balance sheet through an upsized financing that management says leaves it well positioned for near-term growth, government engagement and platform expansion.
More about Origin Therapeutics Holdings, Inc.
Safe Supply Streaming Co Ltd. is a Toronto-based medical technology company focused on health, safety, and wellness solutions, including rapid-response and analytical technologies. Through subsidiaries Safety Strips Tech Corp. and Drug Lab 118 Ltd., it is developing rapid testing products such as fentanyl and drink-spiking detection strips, and it also pursues GLP-1-related health and wellness initiatives aimed at differentiated, technology-driven delivery and accessibility in North American markets.
Average Trading Volume: 150,325
Technical Sentiment Signal: Sell
Current Market Cap: C$8.45M
See more data about SPLY stock on TipRanks’ Stock Analysis page.